Hot Off the Seep: Novel Cyanobacteria with Hefty Implications for Carbon Cycling

Cyanobacteria, microscopic photosynthetic bacteria, have been quietly shaping our planet for billions of years. Responsible for producing the oxygen we breathe, these tiny organisms play a critical role in the global carbon cycle and are now stepping into the spotlight for another reason: their potential to both understand and potentially combat climate change. 

Image of Volcano Island (Baia di Levante) in Italy where the cyanobacterial strains were isolated. Image contains rock formations and a body of water in the foreground with more rock formations in the background.
Baia di Levente. Marine, volcanic seeps in Italy where UTEX 3221 and UTEX 3222 were discovered. Image credit: Adobe Stock.

Recently, researchers discovered two new strains of cyanobacteria, UTEX 3221 and UTEX 3222, thriving in a marine volcanic seep off the coast of Italy. While cyanobacteria are virtually everywhere there is water and light—from calm freshwater ponds to extreme environments like Yellowstone’s hot springs—this particular habitat is remarkable for its naturally high CO₂ levels and acidic conditions. For these newly identified strains, a geochemical setting like marine volcanic seeps have likely driven the evolution of unique traits that could make them valuable for carbon sequestration and industrial applications. 

How can something so small make such a big impact? In this blog, we explore what makes these newly discovered cyanobacteria special and how this research could help address some of the world’s most pressing challenges. 

A Dense Discovery from the Depths of Baia di Levante

The Baia di Levante, nestled near Italy’s Vulcano Island, is a place where geology and biology collide. This shallow marine region is dotted with volcanic seeps that continuously release CO₂ into the water, creating an environment rich in CO₂ while maintaining an acidic (low) pH. Unlike deeper oceanic vents, where sunlight cannot penetrate, Baia di Levante’s shallow waters provide the key ingredient for photosynthesis: light. For most organisms, these conditions would pose significant challenges. But for photosynthetic microorganisms, these particular volcanic seeps offer an abundance of resources: CO₂, sunlight, and water.  

In the hunt for novel photosynthetic species, researchers sampled from seeps in Baia di Levante and identified two novel cyanobacteria strains, UTEX 3221 and UTEX 3222. Among these, UTEX 3222 quickly emerged as a standout, showcasing a combination of traits that make it uniquely promising for research and industrial applications. 

For starters, UTEX 3222 boasts a doubling time of just 2.35 hours—making it one of the fastest-growing cyanobacteria studied to date. In laboratory cultures, it produces over 31 grams of dry biomass per liter, nearly double the yield of some of the current model strains used in biotechnology. It thrives under diverse conditions, tolerating high salinity, varying pH levels, and elevated temperatures, all while maintaining robust growth. 

There are a handful of common lab strains that researchers use to study cyanobacterial photosynthesis in situ. In comparison, UTEX 3222 is much larger than the common laboratory strain, Synechococcus elongatus. Furthermore, UTEX 3222’s cells are noticeably larger and form denser colonies. The strain also contains significantly more carbon, stored in visible white granules within its cells. Finally, researchers found that the strain was considerably heavier’ than S. elongatus: when placed in a test tube, UTEX 3222 rapidly sunk to the bottom, a deviation from other strains. Thus, UTEX 3222 was affectionately given the name “Chonkus” for its particularly dense phenotype.   

Balancing Carbon Capture and Ecosystem Impact

Cyanobacteria have long been recognized for their versatility in industrial applications as they readily convert sunlight and carbon dioxide into biomass. Thus, these photosynthetic bacteria are often used as workhorses for synthesizing materials in a more sustainable way.  Their use spans a wide range of industries, from producing biofuels and bioplastics to synthesizing valuable compounds like vitamins, pigments, and pharmaceuticals. In recent years, they’ve also gained attention for their potential in carbon capture technologies, where their rapid growth and high photosynthetic efficiency can play a pivotal role in reducing atmospheric CO₂ levels. 

In industrial processes, biomass harvesting is often one of the most costly and resource-intensive steps. Traditional methods rely on chemical flocculants or complex filtration systems to separate cells from their growth medium. Chonkus, however, naturally settles to the bottom of a container within hours, forming a dense pellet. This trait could drastically reduce the time, energy, and cost required to collect biomass, making it an attractive candidate for large-scale bioproduction.  

Beyond industry, Chonkus has profound implications for carbon sequestration. In natural ecosystems, cyanobacteria and other photosynthetic organisms play a critical role in the carbon cycle, capturing CO₂ from the atmosphere and converting it into biomass. However, much of this carbon is recycled back into the environment when these organisms die and decompose near an ocean or lake surface. The strain’s rapid settling behavior could change this dynamic. By sinking to deeper ocean layers, its biomass has the potential to transport carbon to regions where it can remain stored for centuries.  

But carbon that sinks doesn’t simply vanish—it interacts with the ocean floor, an environment actively cycling other elements like nitrogen, phosphorus, and sulfur. Introducing large amounts of cyanobacterial biomass to these deep ecosystems could shift nutrient balances and alter microbial communities. While this presents exciting possibilities for carbon sequestration, it also highlights the need for careful study of long-term impacts on ocean nutrient cycling, geochemistry, and biodiversity. 

This behavior is closely tied to the ocean’s biological pump, a natural process that moves organic carbon from the surface to the deep sea. Enhancing this process with organisms like Chonkus could offer a scalable tool for mitigating climate change by increasing the amount of carbon stored in deep ocean layers. However, as we explore these possibilities, it’s essential to understand how such interventions might affect nutrient cycling and biodiversity on the ocean floor. Balancing the promise of carbon sequestration with its ecological implications will be critical for leveraging photosynthetic bacteria in future applications.

Read more about this research in Science.

Why Do We Love Being Scared? The Science Behind Horror Movies

Haunted mansion with pointed towers in a foggy, moonlit forest, creating a spooky, eerie atmosphere.

There’s something oddly captivating about watching a film that makes you jump, scream, or better yet—a film that sticks with you long after watching. Millions of people embrace the fear, willingly diving into the dark world of horror movies. But why? What is the appeal of subjecting ourselves to terror? The reasons we watch and enjoy scary movies go far beyond the jump scares—they’re deeply psychological.

For those who find themselves covering their eyes or clutching the nearest pillow, it might be hard to understand. Yet, as the hair-raising month of October ends, many people spent the 31 days leading up to Halloween watching films designed to scare the daylights out of them. In this blog, we explore why people enjoy fear (or why they don’t) and what psychology reveals about the movies that truly terrify us.

Continue reading “Why Do We Love Being Scared? The Science Behind Horror Movies”

iGEM Grant Winners Tackle Tough Problems in Synthetic Biology

Conceptual image depicting dna strands intertwined with robotic parts.

In June, Promega proudly announced the ten winners of the 2024 Promega iGEM Grant. These extraordinary teams have been hard at work preparing for the iGEM Grand Jamboree, which will take place from October 23-26, 2024, in Paris, France. We interviewed a handful of this year’s grant recipients to learn more about their projects and journeys they’ve taken to reach this exciting milestone. Below are stories from four of the winning teams.

Continue reading “iGEM Grant Winners Tackle Tough Problems in Synthetic Biology”

How Artificial Intelligence Revolutionized the 2024 Paris Olympics

At the end of July, many people across the globe were preparing to tune into the two-week, 2024 Olympic Games in Paris, France. The Olympics were slated to feature several high-profile athletes—including Simone Biles (USA, artistic gymnastics), Eluid Kipchoge (Kenya, marathon) and Marta Vieira da Silva (Brazil, football). However, in the lead-up to the Games, the International Olympic Committee (IOC) focused on a secondary player: Artificial Intelligence (AI). The IOC laid out an ambitious AI agenda aimed to enhance athlete performance, ensure fairness and optimize operations. The 2024 Paris Olympics represent a significant leap forward in integrating AI into the world of sports.

Together, we can unlock AI’s full potential to promote solidarity, further digitalization, improve sustainability and resilience, and reinforce the role of sport in society.” – Olympic AI Agenda

Here, we explore several applications of AI in the 2024 Paris Olympics.

Continue reading “How Artificial Intelligence Revolutionized the 2024 Paris Olympics”

Targeting Dark Kinases for Non-Hormonal, Reversible Male Contraceptives

Contraception, or birth control, is an important tool in family planning. Given the fourfold increase in population over the last century1 there is a clear need for more affordable, reversible, and safe methods of contraception. At present, the responsibility of taking contraceptives falls largely on people with female reproductive organs as there is no current method of birth control for people with male reproductive organs. The search for a non-hormonal, male birth control has been an elusive goal in the field of reproductive health.

A complex, futuristic scene within the outline of a pill.

Recently, a group of scientists from Baylor College of Medicine with contributions from Promega scientists identified a novel compound that 1) inhibits a specific kinase and 2) functions as a reversible male contraceptive. The kinase targeted in this study is the serine/threonine kinase 33 (STK33); a genetic knockout of this gene in male mice is known to cause sterility. The team published their work in Science and utilized a suite of approaches—including DNA-Encoded Libraries (DELs), crystallography, and cellular NanoBRET™ Target Engagement Kinase Assays—to discover a potent inhibitor of STK33 (CDD-2807).  The CDD-2807 inhibitor has shown promising results in inducing reversible contraception in male mice, marking a significant milestone in the development of non-hormonal contraceptive options. Let’s dive into the foundation, novel methodology, collaboration, and implications for this work.

Continue reading “Targeting Dark Kinases for Non-Hormonal, Reversible Male Contraceptives”

From Tracers to Kinetic Selectivity: Highlights from the Target Engagement in Chemical Biology Symposium

In April 2024, Promega hosted the “Target Engagement in Chemical Biology Symposium” at the Kornberg Center, a research and development hub on Promega’s campus in Madison, Wisconsin. The goal of the symposium was to gather interdisciplinary researchers interested in the field of small molecule target engagement to foster collaboration through knowledge sharing and innovation. The symposium featured a 1.5-day agenda packed with 23 speakers, 4 workshops, poster sessions and social events. Over 130 attendees gathered to participate in the multifaceted event, with participants from different geographic regions and in different research sectors from academia to government to industry.  

People gather in a large atrium with scientific posters and table displays.
Attendees gather for the poster session in Kornberg Atrium. Photo by Anna Bennett (Promega Corporation)

The symposium highlighted the collective commitment to overcoming the challenges in drug discovery by developing more targeted and efficacious treatments, driven by a shared determination to create innovative solutions that address unmet medical needs. While we cannot share all the exciting research presented at the symposium, we are thrilled to highlight a few talks that exemplify the novel work and collaborative spirit of this research community.  

Continue reading “From Tracers to Kinetic Selectivity: Highlights from the Target Engagement in Chemical Biology Symposium”

Rooted in Resilience: The Future of Pest-Resistant Crops

Sunlight illuminating crops growing in a field

Farmers everywhere strive to protect their crops and ensure a stable food supply while minimizing environmental harm. A promising approach to achieving this leverages a plant’s built-in defense mechanisms, reducing the need for chemical interventions. Many geneticists and agronomists lean on technologies that can automate and streamline nucleic acid extraction and pathogen detection to identify naturally pest resistant crops and, ultimately, keep up with the changing agricultural landscape.  

Continue reading “Rooted in Resilience: The Future of Pest-Resistant Crops”

Transform Your Research Lab with our Comprehensive Automation Resources

Futuristic Artificial Intelligence Robotic Arm Operates and Moves a Metal Object, Picks It Up and Puts it Down. Scene is Taken in a High Tech Research Laboratory with Modern Equipment.

In an era where science moves at a rapid pace, integrating automation into your lab is not just beneficial but essential. When you automate your lab, you free up an invaluable resource: time. From scaling up operations and handling increased demand to improving consistency and reducing manual errors, automation can be the key to achieving higher throughput, saving costs, and—most importantly—enabling researchers to focus on the science rather than the process. However, embarking on a lab automation project requires careful planning, clear goals and an understanding of the intricacies involved in automating complex biological workflows.

Continue reading “Transform Your Research Lab with our Comprehensive Automation Resources”

Transforming Forensic Science with DNA from Dust

A ray of sun coming through the wooden shutters, illuminates dust on the inside of a dark room. Close up, selective focus. Vintage background. This image is licensed from Adobe Stock.

In the evolving field of forensic science, a study by Fantinato et al. has opened new avenues in using DNA extraction and analysis to recover important information from crime scenes. Their work, “The Invisible Witness: Air and Dust as DNA Evidence of Human Occupancy in Indoor Premises,” focuses on extracting DNA from air and dust. This novel approach could revolutionize how crime scenes are investigated, especially in scenarios where traditional evidence—like fingerprints or bodily fluids—is scarce, degraded or has been removed from surfaces.

Continue reading “Transforming Forensic Science with DNA from Dust”

Promega qPCR Grant Series #3: Immunotherapy Researcher, Dr. Sabrina Alves dos Reis 

Professional headshot image of Dr. Sabrina Alves dos Reis, subject of the blog post
Sabrina Alves dos Reis

In our third and final installment of the Promega qPCR Grant Recipient blog series, we highlight Dr. Sabrina Alves dos Reis, a trained immunotherapy researcher. Her work has focused on developing tools for more accessible cancer therapies using CAR-T cells. Here, we explore Dr. Alves dos Reis’ academic and scientific journeys, highlight influential mentorship and foreshadow her plans for the Promega qPCR grant funds. 

Dr. Alves dos Reis’ career began with a strong affinity for biology. As an undergraduate student, she pursued a degree in biological science, where she developed a foundational understanding for designing and developing research projects. As her passion for science heightened, she decided to continue her journey in science, culminating in a PhD at the Fundação Oswaldo Cruz Institute in Rio de Janeiro, Brazil. Her research projects focused on the unexplored territory of adipose tissue as a site for Mycobacterium leprae—or leprosy bacillus—infection. She mentioned that this work piqued her curiosity for improving immunotherapies and laid the foundation for her future in cancer research.  

Continue reading “Promega qPCR Grant Series #3: Immunotherapy Researcher, Dr. Sabrina Alves dos Reis “